 Jennifer Jung
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Porencephaly | 2 | 2019 | 6 | 1.300 |
Why?
| | Cataract | 3 | 2019 | 208 | 1.180 |
Why?
| | Retinopathy of Prematurity | 5 | 2024 | 138 | 1.090 |
Why?
| | Collagen Type IV | 2 | 2019 | 22 | 0.800 |
Why?
| | Vigabatrin | 1 | 2021 | 18 | 0.730 |
Why?
| | Abnormalities, Multiple | 2 | 2019 | 178 | 0.700 |
Why?
| | Birth Weight | 4 | 2024 | 499 | 0.680 |
Why?
| | Anticonvulsants | 1 | 2021 | 202 | 0.630 |
Why?
| | Ophthalmology | 1 | 2019 | 82 | 0.600 |
Why?
| | Visual Acuity | 4 | 2025 | 322 | 0.510 |
Why?
| | Neonatal Screening | 1 | 2017 | 164 | 0.490 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 307 | 0.470 |
Why?
| | Uveitis | 2 | 2024 | 127 | 0.420 |
Why?
| | DNA | 1 | 2019 | 1394 | 0.390 |
Why?
| | Mutation | 2 | 2019 | 3696 | 0.370 |
Why?
| | Retinal Diseases | 2 | 2025 | 86 | 0.350 |
Why?
| | Algorithms | 1 | 2017 | 1614 | 0.320 |
Why?
| | Infant | 10 | 2025 | 9001 | 0.280 |
Why?
| | Retrospective Studies | 13 | 2025 | 14471 | 0.250 |
Why?
| | Gestational Age | 5 | 2024 | 871 | 0.250 |
Why?
| | Nephritis, Interstitial | 1 | 2024 | 13 | 0.230 |
Why?
| | Intravitreal Injections | 1 | 2024 | 55 | 0.230 |
Why?
| | Fluocinolone Acetonide | 1 | 2024 | 19 | 0.230 |
Why?
| | Pyrimidinones | 1 | 2025 | 103 | 0.230 |
Why?
| | Drug Implants | 1 | 2024 | 83 | 0.220 |
Why?
| | Diseases in Twins | 1 | 2024 | 176 | 0.220 |
Why?
| | Pyridones | 1 | 2025 | 158 | 0.210 |
Why?
| | Cranial Nerve Diseases | 2 | 2020 | 41 | 0.210 |
Why?
| | Glucocorticoids | 2 | 2024 | 573 | 0.210 |
Why?
| | Arachnoid Cysts | 1 | 2023 | 6 | 0.210 |
Why?
| | Twins | 1 | 2024 | 249 | 0.210 |
Why?
| | Papilledema | 1 | 2023 | 39 | 0.200 |
Why?
| | Electroretinography | 1 | 2021 | 44 | 0.180 |
Why?
| | Pontine Tegmentum | 1 | 2020 | 4 | 0.180 |
Why?
| | Cerebellar Diseases | 1 | 2020 | 22 | 0.180 |
Why?
| | Nervous System Malformations | 1 | 2020 | 37 | 0.170 |
Why?
| | Oculomotor Muscles | 1 | 2020 | 37 | 0.170 |
Why?
| | Strabismus | 1 | 2020 | 28 | 0.170 |
Why?
| | Eye Diseases | 1 | 2020 | 80 | 0.170 |
Why?
| | Retinal Hemorrhage | 1 | 2019 | 19 | 0.170 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2020 | 57 | 0.160 |
Why?
| | Head Injuries, Closed | 1 | 2019 | 50 | 0.160 |
Why?
| | Infant, Newborn | 6 | 2024 | 5740 | 0.160 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 880 | 0.160 |
Why?
| | Retina | 1 | 2021 | 274 | 0.150 |
Why?
| | Vitrectomy | 1 | 2018 | 65 | 0.150 |
Why?
| | Epithelium, Corneal | 1 | 2018 | 40 | 0.150 |
Why?
| | Corneal Diseases | 1 | 2018 | 34 | 0.150 |
Why?
| | Eye Injuries | 1 | 2018 | 46 | 0.150 |
Why?
| | Serum | 1 | 2018 | 57 | 0.150 |
Why?
| | DNA Mutational Analysis | 1 | 2019 | 385 | 0.150 |
Why?
| | Pedigree | 1 | 2019 | 485 | 0.150 |
Why?
| | Ophthalmic Solutions | 1 | 2018 | 73 | 0.150 |
Why?
| | Retinal Detachment | 1 | 2018 | 56 | 0.140 |
Why?
| | Infant, Premature | 2 | 2019 | 538 | 0.140 |
Why?
| | Child | 9 | 2025 | 20805 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2020 | 259 | 0.140 |
Why?
| | Cataract Extraction | 1 | 2018 | 96 | 0.140 |
Why?
| | Laser Coagulation | 1 | 2017 | 57 | 0.140 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 67 | 0.130 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 14 | 0.130 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.130 |
Why?
| | Humans | 18 | 2025 | 128495 | 0.130 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 135 | 0.130 |
Why?
| | Male | 13 | 2025 | 63043 | 0.130 |
Why?
| | Female | 14 | 2025 | 68266 | 0.130 |
Why?
| | Hyperlipidemias | 1 | 2016 | 125 | 0.120 |
Why?
| | Disease Management | 1 | 2019 | 584 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 10487 | 0.120 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 223 | 0.110 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2019 | 377 | 0.110 |
Why?
| | Risk Factors | 6 | 2024 | 9737 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1817 | 0.100 |
Why?
| | Phenotype | 1 | 2019 | 3051 | 0.090 |
Why?
| | Cohort Studies | 2 | 2017 | 5402 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 20304 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2024 | 4874 | 0.070 |
Why?
| | Risk Assessment | 1 | 2017 | 3232 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3387 | 0.070 |
Why?
| | Brain | 1 | 2019 | 2624 | 0.070 |
Why?
| | beta 2-Microglobulin | 1 | 2024 | 47 | 0.060 |
Why?
| | Fluorescein Angiography | 1 | 2025 | 143 | 0.060 |
Why?
| | Tertiary Care Centers | 1 | 2025 | 150 | 0.060 |
Why?
| | Mycophenolic Acid | 1 | 2024 | 89 | 0.060 |
Why?
| | Time Factors | 3 | 2019 | 6505 | 0.050 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 186 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 249 | 0.050 |
Why?
| | Rupture | 1 | 2023 | 89 | 0.050 |
Why?
| | Intraocular Pressure | 1 | 2024 | 297 | 0.050 |
Why?
| | Vision Disorders | 1 | 2023 | 135 | 0.050 |
Why?
| | Myotomy | 1 | 2020 | 11 | 0.040 |
Why?
| | Vision, Binocular | 1 | 2020 | 17 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 684 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 1951 | 0.040 |
Why?
| | United States | 1 | 2017 | 13840 | 0.040 |
Why?
| | Eye Movements | 1 | 2020 | 59 | 0.040 |
Why?
| | Remission, Spontaneous | 1 | 2019 | 37 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 323 | 0.040 |
Why?
| | Microscopy, Acoustic | 1 | 2018 | 8 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 35 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2024 | 10162 | 0.040 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2018 | 38 | 0.040 |
Why?
| | Colorado | 2 | 2018 | 4399 | 0.040 |
Why?
| | Physical Examination | 1 | 2019 | 233 | 0.040 |
Why?
| | Registries | 1 | 2024 | 1883 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2016 | 61 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 58 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 268 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 128 | 0.030 |
Why?
| | Child Abuse | 1 | 2019 | 517 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 729 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2638 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3780 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2719 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7057 | 0.020 |
Why?
| | Aged | 1 | 2020 | 21974 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 30921 | 0.010 |
Why?
| | Adult | 1 | 2020 | 35299 | 0.010 |
Why?
|
|
Jung's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|